Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Feline immunodeficiency virus vaccine
- Development stage
- Preclinical
- Lead developer
- Fort Dodge Laboratories
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
TVG's Feline Immunodeficiency Virus (FIV) vaccine is a veterinary viral-vector vaccine currently in preclinical development for the prevention of FIV infection in cats. Developed by The Vaccine Group (TVG), the vaccine utilizes a proprietary herpesvirus-based viral vector platform engineered to express specific FIV antigens. This approach is designed to stimulate a robust and protective immune response, including both cellular and humoral components, to protect cats from the immunodeficiency syndrome caused by the FIV lentivirus. The use of a herpesvirus vector is intended to enhance the immunogenicity and efficacy of the vaccine compared to traditional platforms.
- Other names
- FIV vaccineTVG FIV vaccineherpesvirus-based viral-vector FIV vaccine
02
Targets
FIV antigens (Feline immunodeficiency virus antigens)
Beyond the preview
Go deeper on Feline immunodeficiency virus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Feline immunodeficiency virus vaccine.